Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Serina Therapeutics Inc (SER)

$1.63 +0.03 (1.88%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	23.84M
Revenue (ttm)	130,000.00
Net Income (ttm)	-19.18M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-14,753.85%
Debt to Equity Ratio	1.82

Volume	86,100
Avg Vol	4,051,260
Day's Range	N/A - N/A
Shares Out	14.90M
Stochastic %K	32%
Beta	1.15
Analysts	Strong Sell
Price Target	$13.00

Company Profile

Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in phase 1 clinical trial; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214, a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has c...

Industry: Biotechnology

Sector: Healthcare

Phone: 256 327 9630

Website: serinatherapeutics.com

Address:

601 Genome Way, Suite 2001, Huntsville, United States

SuperGreenToday May. 12 at 12:44 PM

$SER

0 · Reply

MauriceMauriceMaurice May. 11 at 10:24 PM

$SMMT $EGG $SER

0 · Reply

Monogg May. 5 at 10:35 PM

$SER These are scammers—they’ve approved another dilution up to 2 million shares, with the first step being 125,000. Be careful! Do not buy shares of these fraudsters.

0 · Reply

dthekang May. 4 at 6:53 PM

$SER

0 · Reply

OfficialStocktwitsUser May. 1 at 6:16 PM

$SER RSI: 39.38, MACD: -0.0603 Vol: 0.10, MA20: 1.96, MA50: 1.92 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

gmc109 Apr. 27 at 4:15 PM

$SER in few days to 4$?

0 · Reply

KaShing01 Apr. 27 at 2:35 PM

$SER

0 · Reply

dthekang Apr. 17 at 1:42 PM

$SER what the farks goin on here eh?

0 · Reply

focafoca99 Apr. 7 at 9:08 PM

$SER is promoting a summit presentation on POZ-based lipid nanoparticles and ionizable lipids.

0 · Reply

Eliza1 Apr. 7 at 4:13 PM

$SER a PR after the presentation would give this stock a boost. Obviously, they have something positive to say.

1 · Reply

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

2026-04-02T20:21:42.000Z - 5 weeks ago

Serina Therapeutics announces NYSE acceptance of plan to regain compliance

Apr 2, 2026, 4:13 PM EDT - 5 weeks ago

Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan

Mar 24, 2026, 6:00 AM EDT - 7 weeks ago

Serina Therapeutics to Present at the 38th Annual Roth Conference

2026-03-18T20:30:41.000Z - 7 weeks ago

Serina Therapeutics names Greg Bailey co-chairman

Mar 18, 2026, 4:10 PM EDT - 7 weeks ago

Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanced Parkinson's Disease

2026-02-24T21:37:35.000Z - 2 months ago

Serina Therapeutics doses first patient in SER-252 trial

Feb 24, 2026, 4:05 PM EST - 2 months ago

Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

2026-02-19T11:20:45.000Z - 2 months ago

Serina Therapeutics says first patient enrolled in Phase 1b trial of SER-252

Feb 19, 2026, 6:00 AM EST - 2 months ago

Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson's Disease

Feb 3, 2026, 6:00 AM EST - 3 months ago

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event

2026-01-30T22:25:13.000Z - 3 months ago

Serina Therapeutics files to sell 7.72M shares of common stock for holders

2026-01-29T14:53:03.000Z - 3 months ago

This Is Why Serina Therapeutics Stock (SER) Rocketed Today

2026-01-28T21:31:30.000Z - 3 months ago

Serina Therapeutics announces FDA clearance of SER-252 new drug application

Jan 28, 2026, 4:12 PM EST - 3 months ago

Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson's disease

2026-01-15T21:40:23.000Z - 4 months ago

Serina Therapeutics receives NYSE deficiency notice on equity standards

Jan 15, 2026, 4:30 PM EST - 4 months ago

Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity

Dec 11, 2025, 4:15 PM EST - 5 months ago

Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry

2025-12-10T21:45:32.000Z - 5 months ago

Serina Therapeutics submits complete response to FDA clinical hold letter

Dec 10, 2025, 4:30 PM EST - 5 months ago

Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program

2025-11-13T11:15:52.000Z - 6 months ago

Serina Therapeutics reports Q3 EPS (45c) vs. 13c last year

Nov 13, 2025, 6:10 AM EST - 6 months ago

Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights

2025-11-03T11:16:17.000Z - 6 months ago

Serina Therapeutics says FDA places clinical hold on IND for SER-252

Nov 3, 2025, 6:05 AM EST - 6 months ago

Serina Therapeutics Provides Regulatory Update on SER-252 Program

Oct 8, 2025, 11:00 AM EDT - 7 months ago

Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicians, and Investors

Oct 6, 2025, 4:15 PM EDT - 7 months ago

Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson's Disease

2025-09-09T20:00:41.000Z - 8 months ago

Serina Therapeutics Inc trading resumes

2025-09-09T19:30:14.000Z - 8 months ago

Serina Therapeutics announces agreement to access up to $20M in financing

Sep 9, 2025, 3:20 PM EDT - 8 months ago

Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson's Disease

2025-09-09T19:15:24.000Z - 8 months ago

Serina Therapeutics Inc trading halted, news pending

Sep 8, 2025, 6:00 AM EDT - 8 months ago

Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

2025-08-27T01:27:00.000Z - 9 months ago

Serina Therapeutics Stock (SER) Soars 20% on FDA Support

2025-08-26T13:45:11.000Z - 9 months ago

Serina Therapeutics Inc trading resumes

2025-08-26T13:40:26.000Z - 9 months ago

Serina Therapeutics Inc trading halted, volatility trading pause

Aug 25, 2025, 4:15 PM EDT - 9 months ago

Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson's Disease under 505(b)(2) NDA Pathway

Aug 11, 2025, 4:30 PM EDT - 9 months ago

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

Jul 29, 2025, 6:44 AM EDT - 10 months ago

Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD)

Jul 28, 2025, 6:00 AM EDT - 10 months ago

Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Jul 10, 2025, 4:10 PM EDT - 10 months ago

Serina Therapeutics Makes Grant to New Employee Under Inducement Plan

Jul 1, 2025, 4:15 PM EDT - 11 months ago

Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting

Jun 23, 2025, 7:24 PM EDT - 11 months ago

Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025

Jun 17, 2025, 8:30 PM EDT - 11 months ago

UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strategic Partnership with M42

Jun 17, 2025, 6:00 AM EDT - 11 months ago

Serina Therapeutics Congratulates Juvenescence Ltd. on $150M Series B Funding and Strategic Partnership with M42

Jun 9, 2025, 4:05 PM EDT - 1 year ago

Registration Is Now Open For Tribe Public's CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector the Smartest Bet in Today's Volatile Market?"

May 22, 2025, 4:50 PM EDT - 1 year ago

Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors

May 14, 2025, 3:15 PM EDT - 1 year ago

Serina Therapeutics Makes Grants to New Employees Under Inducement Plan

May 8, 2025, 4:23 PM EDT - 1 year ago

Serina Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights

Apr 29, 2025, 6:00 AM EDT - 1 year ago

Serina Therapeutics to Present at JonesResearch Virtual CNS Day

Apr 15, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit

Apr 8, 2025, 4:30 PM EDT - 1 year ago

Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease

Apr 7, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the Jones Healthcare and Technology Innovation Conference

Mar 24, 2025, 4:30 PM EDT - 1 year ago

Serina Therapeutics Reports Full Year 2024 Financial Results and Recent Business Highlights

Mar 24, 2025, 6:30 AM EDT - 1 year ago

Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting

Feb 12, 2025, 4:15 PM EST - 1 year ago

Serina Therapeutics Appoints Dr. Jay Venkatesan to its Board of Directors

Feb 3, 2025, 4:30 PM EST - 1 year ago

Serina Therapeutics Receives Second $5 Million Tranche to Strengthen Cash Position Ahead of Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Jan 15, 2025, 4:05 PM EST - 1 year ago

Serina Therapeutics Announces Sale of UniverXome Subsidiary

Jan 14, 2025, 5:25 PM EST - 1 year ago

Serina Therapeutics Welcomes Karen J. Wilson to its Board of Directors

Dec 16, 2024, 6:00 AM EST - 1 year ago

Serina Therapeutics to Present at Tribe Public's Webinar Event "Enabling Continuous Drug Delivery for Parkinson's Disease & Beyond" on Wednesday, December 18, 2024

Dec 11, 2024, 6:05 AM EST - 1 year ago

Serina Therapeutics to Present at the 3rd Annual LNP Immunogenicity & Toxicity Summit

Dec 2, 2024, 5:22 PM EST - 1 year ago

Serina Therapeutics Secures $10 Million Financing to Continue Advancing Lead IND Candidate into Phase 1 Clinical Trial in Advanced Parkinson's Disease Patients

Nov 12, 2024, 5:00 PM EST - 1 year ago

Serina Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights

Sep 4, 2024, 6:42 PM EDT - 1 year ago

Serina Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 9, 2024, 4:15 PM EDT - 1 year ago

Serina Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Highlights

Jul 29, 2024, 8:30 AM EDT - 1 year ago

Serina Therapeutics to Present Novel Data on POZ-Lipid Technology Potentially Enhancing Safety and Efficacy of mRNA LNP Formulations at the 4th mRNA-Based Therapeutics Summit

Jul 18, 2024, 5:00 PM EDT - 1 year ago

Serina Therapeutics Appoints Srini Tenjarla, Ph.D. as Senior Vice President of CMC and Formulation

May 14, 2024, 4:05 PM EDT - 2 years ago

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Apr 17, 2024, 4:05 PM EDT - 2 years ago

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

SuperGreenToday May. 12 at 12:44 PM

$SER

0 · Reply

MauriceMauriceMaurice May. 11 at 10:24 PM

$SMMT $EGG $SER

0 · Reply

Monogg May. 5 at 10:35 PM

$SER These are scammers—they’ve approved another dilution up to 2 million shares, with the first step being 125,000. Be careful! Do not buy shares of these fraudsters.

0 · Reply

dthekang May. 4 at 6:53 PM

$SER

0 · Reply

OfficialStocktwitsUser May. 1 at 6:16 PM

0 · Reply

gmc109 Apr. 27 at 4:15 PM

$SER in few days to 4$?

0 · Reply

KaShing01 Apr. 27 at 2:35 PM

$SER

0 · Reply

dthekang Apr. 17 at 1:42 PM

$SER what the farks goin on here eh?

0 · Reply

focafoca99 Apr. 7 at 9:08 PM

$SER is promoting a summit presentation on POZ-based lipid nanoparticles and ionizable lipids.

0 · Reply

Eliza1 Apr. 7 at 4:13 PM

$SER a PR after the presentation would give this stock a boost. Obviously, they have something positive to say.

1 · Reply

Eliza1 Apr. 7 at 1:28 PM

$SER https://finance.yahoo.com/sectors/healthcare/articles/serina-therapeutics-present-5th-lnp-100000383.html

0 · Reply

focafoca99 Apr. 3 at 8:30 PM

$SER says NYSE American accepted its compliance plan, which removes the immediate listing overhang but leaves execution to prove out.

0 · Reply

Eliza1 Apr. 2 at 11:41 PM

$SWMR $EVTV $SER all could go much higher Monday.

0 · Reply

Eliza1 Apr. 2 at 9:16 PM

$SER hmmm , perhaps with this news this stock can head up to 4 or 5 on Monday.

0 · Reply

gamgee11 Apr. 2 at 8:17 PM

$SER nice green

0 · Reply

Eliza1 Apr. 1 at 11:57 PM

$SER like $CYCN, OPEN AT $4 +

0 · Reply

Eliza1 Mar. 31 at 6:16 PM

$EVTV $COMP IS UP 3%! the small caps will follow-trade accordingly which means cover your shorts now-$SER $SWMR are all included at the very least.

0 · Reply

Eliza1 Mar. 31 at 5:22 PM

$SER $5 here we come

0 · Reply

Eliza1 Mar. 31 at 5:20 PM

$SER forget $COMP-LOOK at $QQQ ,

0 · Reply

Eliza1 Mar. 31 at 5:14 PM

$SER OMG look at $COMP- now I am very bullish and the small caps will catch up and then some!!

0 · Reply

1.0.0